ビオフェルミン製薬(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|---|---|---|
| 東証1部 | 医薬品 | 4517/E00960 | BIOFERMIN PHARMACEUTICAL CO.,LTD. |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|---|---|---|---|---|---|---|---|---|
| 2016/09/02 | 日証協 | 25,554株 | -2.2% | 226株 | -91.27% | 38,149株 | +1.61% | 1,105株 | -15% |
| 2016/08/26 | 日証協 | 26,128株 | +1.55% | 2,590株 | +331.67% | 37,544株 | +2.17% | 1,300株 | +44.44% |
| 2016/08/19 | 日証協 | 25,728株 | +0.28% | 600株 | -76.35% | 36,745株 | +1.86% | 900株 | +26.23% |
| 2016/08/12 | 日証協 | 25,656株 | -0.15% | 2,537株 | +21.56% | 36,073株 | -0.19% | 713株 | -33.43% |
| 2016/08/05 | 日証協 | 25,694株 | +2.82% | 2,087株 | -24.66% | 36,140株 | +0.37% | 1,071株 | -33.06% |
| 2016/07/29 | 日証協 | 24,990株 | -6.02% | 2,770株 | +361.67% | 36,006株 | +1.98% | 1,600株 | +220% |
| 2016/07/22 | 日証協 | 26,590株 | +0.38% | 600株 | -96% | 35,306株 | +0.86% | 500株 | +25% |
| 2016/07/15 | 日証協 | 26,490株 | -29.15% | 14,990株 | +317.55% | 35,006株 | -39.75% | 400株 | -20% |
| 2016/07/08 | 日証協 | 37,390株 | -2.53% | 3,590株 | +124.38% | 58,106株 | -1.31% | 500株 | -60.66% |
| 2016/07/01 | 日証協 | 38,360株 | -31.82% | 1,600株 | -98.23% | 58,876株 | -38.23% | 1,271株 | -98.79% |
| 2016/06/24 | 日証協 | 56,260株 | +134.81% | 90,460株 | +6095.89% | 95,310株 | +226.29% | 105,100株 | +4904.76% |
| 2016/06/17 | 日証協 | 23,960株 | -0.54% | 1,460株 | -2.67% | 29,210株 | +0.17% | 2,100株 | +10.29% |
| 2016/06/10 | 日証協 | 24,090株 | +4.33% | 1,500株 | -11.76% | 29,159株 | +4.31% | 1,904株 | -34.34% |
| 2016/06/03 | 日証協 | 23,090株 | -7.28% | 1,700株 | +19.38% | 27,955株 | -3.12% | 2,900株 | +44.93% |
| 2016/05/27 | 日証協 | 24,902株 | -9.12% | 1,424株 | -59.59% | 28,855株 | -3.99% | 2,001株 | -75.89% |
| 2016/05/20 | 日証協 | 27,402株 | -18.42% | 3,524株 | -80.64% | 30,054株 | +6% | 8,300株 | +653.86% |
| 2016/05/13 | 日証協 | 33,590株 | +50.7% | 18,200株 | +2933.33% | 28,354株 | +1.07% | 1,101株 | +57.29% |
| 2016/05/06 | 日証協 | 22,290株 | 0% | 600株 | +500% | 28,053株 | -4.43% | 700株 | +250% |
| 2016/04/28 | 日証協 | 22,290株 | -0.89% | 100株 | -85.71% | 29,353株 | -0.68% | 200株 | +100% |
※株式分割は考慮していませんのでご注意ください。